US2005164230A1PendingUtilityA1
Assays for the detection of microtubule depolymerization inhibitors
Priority: Apr 14, 1998Filed: Aug 25, 2004Published: Jul 28, 2005
Est. expiryApr 14, 2018(expired)· nominal 20-yr term from priority
G01N 2333/4703C12N 9/14C12N 2799/026G01N 21/6458C12Q 1/42G01N 21/6428C12Q 1/37G01N 33/68
51
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
This invention provides methods for the screening and identification of agents having potent effects on the progression of the cell cycle. In one embodiment, the methods involve contacting a polymerized microtubule with a microtubule severing protein or a microtubule depolymerizing protein in the presence of an ATP or a GTP and a test agent; and (ii) detecting the formation of tubulin monomers, dimers or oligomers. The p60 subunit of katanin provides a particularly preferred microtubule severing protein possessing both ATPase and microtubule severing activities.
Claims
exact text as granted — not AI-modified1 - 25 . (canceled)
26 . An isolated polypeptide having microtubule severing activity, said polypeptide comprising an amino acid sequence that is encoded by a nucleic acid sequence that hybridizes under stringent conditions with a nucleic acid sequence that encodes SEQ ID NO:1.
27 . The polypeptide of claim 26 , wherein said polypeptide comprises SEQ ID NO:1.
28 . The polypeptide of claim 26 , wherein said polypeptide:
1) comprises at least 8 contiguous amino acids of SEQ ID NO: 1; 2) elicits the production of an antibody that specifically binds to SEQ ID NO:1; and 3) does not bind to antiserum that is raised against SEQ ID NO:1, and that has been fully immunosorbed with SEQ ID NO:1.
29 . The polypeptide of claim 26 , wherein said polypeptide is the pelypeptide consists of SEQ ID NO:1.
30 - 33 . (canceled)
34 . A kit for screening for agents that modulate microtubule depolymerization, said kit comprising one or more containers containing one or more of an isolated microtubule severing protein and a microtubule depolymerizing protein.
35 . The kit of claim 34 , further comprising a polymerized microtubule labeled with 4′-6-diamidino-2-phenylindole (DAPI).
36 . The kit of claim 34 , wherein said microtubule is stabilized by contact with an agent chosen from one or more of paclitaxel, paclitaxel analogue, and non-hydrolyzable nucleotide GTP analogue.
37 . The kit of claim 36 , wherein said microtubule is attached to a solid surface.
38 . The kit of claim 37 , wherein said microtubule is attached to said surface by binding with a motor protein.
39 . The kit of claim 34 , wherein said microtubule severing protein or microtubule depolymerizing protein is selected from the group consisting of katanin polypeptide, p60 subunit of katanin polypeptide, Xenopus kinesin central motor 1 (XKCM1) polypeptide, and a stathmin (OP18) polypeptide.
40 - 41 . (canceled)
42 . The kit of claim 34 , wherein said one or more of microtubule severing protein and microtubule depolymerizing protein is attached to a solid surface.
43 - 59 . (canceled)
60 . The polypeptide of claim 26 , wherein said nucleic acid sequence that encodes SEQ ID NO:1 is listed in Genbank AF052191.
61 . The polypeptide of claim 26 , wherein said polypeptide comprises SEQ ID NO:1 having conservative substitutions.
62 . The polypeptide of claim 26 , wherein said polypeptide consists of SEQ ID NO:1 having conservative substitutions.
63 . The polypeptide of claim 26 , wherein said hybridization conditions comprise hybridization at 42° C. overnight in 50% formamide.
64 . The polypeptide of claim 26 , wherein said isolated polypeptide is recombinant.
65 . An isolated polypeptide comprising SEQ ID NO:1 and having microtubule severing activity.
66 . An isolated polypeptide consisting of SEQ ID NO:1.
67 . The kit of claim 34 , further comprising tubulin that is labeled with a label chosen from one or more of 4′-6-diamidino-2-phenylindole (DAPI), anilinonapthalene sulfonate (ANS), bis-ANS (Bis-anilinonapthalene sulfonate), N-phenyl-1-naphthylene (NPN), ruthernium red, cresol violet, and 4-(dicyanovinyl)julolidine (DCVJ).
68 . The kit of claim 34 , further comprising tubulin that is labeled with 4′-6-diamidino-2-phenylindole (DAPI).
69 . The kit of claim 34 , wherein said microtubule depolymerizing protein comprises Xenopus kinesin central motor 1 (XKCM1) polypeptide.
70 . The kit of claim 34 , wherein said microtubule depolymerizing protein comprises stathmin (OP18) polypeptide.
71 . The kit of claim 34 , wherein said microtubule depolymerizing protein comprises katanin polypeptide.
72 . The kit of claim 34 , wherein said microtubule depolymerizing protein comprises a p60 subunit of katanin polypeptide.
73 . The kit of claim 37 , wherein said microtubule is attached to said surface by binding with a molecule chosen from one or more of inactivated microtubule motor protein, avidin-biotin linkage, anti-tubulin antibody, microtubule binding protein (MAP), polyarginine, polyhistidine, and polylysine.
74 . A kit comprising the polypeptide of claim 26.Join the waitlist — get patent alerts
Track US2005164230A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.